Grants and Contributions:
Title:
Development of lipid nanoparticulate drugs for immunotolerogenic therapy of autoimmune/inflammatory disease
Agreement Number:
909840
Agreement Value:
$131,560.00
Agreement Date:
Jul 1, 2018 - Jul 31, 2019
Description:
This project aims to develop effective immunomodulatory formulations to induce immune tolerance as a therapeutic strategy for autoimmune and inflammatory diseases.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Vancouver, British Columbia, CA V6S 1C3
Reference Number:
172-2018-2019-Q2-909840
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
824601991
Recipient Type:
For-profit organization
Recipient's Legal Name:
Integrated Nanotherapeutics Inc.
Federal Riding Name:
Vancouver Quadra
Federal Riding Number:
59039
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
541710